Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia

Non-relapse mortality due to GVHD and infections represents a major source of morbidity and mortality in pediatric HSCT recipients. Post-transplant cyclophosphamide (PTCy) has emerged as an effective and safe GVHD prophylaxis strategy, with improved GVHD and relapse-free survival in matched (related...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheikh, Irtiza N., Alqahtani, Shaikha, Ragoonanan, Dristhi, Tewari, Priti, Petropoulos, Demetrios, Mahadeo, Kris M., Popat, Uday, Shpall, Elizabeth J., Khazal, Sajad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368975/
https://www.ncbi.nlm.nih.gov/pubmed/35955881
http://dx.doi.org/10.3390/ijms23158748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368975/
https://www.ncbi.nlm.nih.gov/pubmed/35955881
http://dx.doi.org/10.3390/ijms23158748

Ejemplares similares